A Phase I Study of AZD1480 in Patients With Advanced Solid Malignancies and Advanced Hepatocellular Carcinoma in the Escalation Phase,Non-Small Cell Lung Cancer(NSCLC) and Non-smokers With Lung Metastasis and Gastric Cancer and Solid Tumour in the Expansion Phase.

Clinical trial NCT01219543 · TERMINATED

Trial details

NCT number: NCT01219543
Sponsor: AstraZeneca
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumour Advanced Solid Malignancies Child-Pugh A to B7 Advanced Hepatocellular Carcinoma EGFR and/or ROS Mutant NSCLC Lung Metastasis Carcinoma Gastric Cancer

Start date: 2010-11-01
Primary completion: 2012-12-01
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.